Plasmides CRISPR IRAK
Santa Cruz Biotechnology, Inc. propose une très large gamme de produits de modification des gènes incluant les plasmides de Knockout CRISPR/Cas9 et Double Nickase CRISPR pour le gene silencing. Les gene silencers IRAK sont disponibles en plasmides Knockout CRISPR/Cas9 IRAK et en plasmides Double Nickase IRAK. Les Plasmides d'Activation CRISPR/dCas9 IRAK et les Systèmes d' Activation Lenti CRISPR pour l'activation de gène sont également disponibles. Les Gene Silencers et Activateurs permettent d'étudier les gènes en combinaison avec des anticorps utilisés pour la détection de l'expression protéique.
IRAK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Nom du produit | CATALOG # | Species | Applications | MARQUEUR | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|
Plasmide CRISPR/Cas9 KO IRAK-M (h2) | sc-403219-KO-2 | h | Gene Knockout | GFP | 0 | ||
Plasmid HDR IRAK-M (h2) | sc-403219-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
Plasmide Double Nickase (h) IRAK-M | sc-403219-NIC | h | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (h2) IRAK-M | sc-403219-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO IRAK-M (m2) | sc-428667-KO-2 | m | Gene Knockout | GFP | 0 | ||
Plasmide Double Nickase (m) IRAK-M | sc-428667-NIC | m | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (m2) IRAK-M | sc-428667-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO IRAK-1 (h) | sc-400264 | h | Gene Knockout | GFP | 1 | ||
Plasmid HDR IRAK-1 (h) | sc-400264-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
Plasmide Double Nickase (h) IRAK-1 | sc-400264-NIC | h | Gene Knockout | Puromycin | 1 | ||
Plasmide Double Nickase (h2) IRAK-1 | sc-400264-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
Plasmide CRISPR/Cas9 KO IRAK-1 (m) | sc-421100 | m | Gene Knockout | GFP | 0 | ||
Plasmide Double Nickase (m) IRAK-1 | sc-421100-NIC | m | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (m2) IRAK-1 | sc-421100-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO IRAK-2 (h) | sc-404304 | h | Gene Knockout | GFP | 0 | ||
Plasmid HDR IRAK-2 (h) | sc-404304-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Plasmide Double Nickase (h) IRAK-2 | sc-404304-NIC | h | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (h2) IRAK-2 | sc-404304-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO IRAK-2 (m) | sc-430883 | m | Gene Knockout | GFP | 0 | ||
Plasmid HDR IRAK-2 (m) | sc-430883-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Plasmide Double Nickase (m) IRAK-2 | sc-430883-NIC | m | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (m2) IRAK-2 | sc-430883-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Plasmide CRISPR/Cas9 KO IRAK-4 (h) | sc-416405 | h | Gene Knockout | GFP | 1 | ||
Plasmid HDR IRAK-4 (h) | sc-416405-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
Plasmide Double Nickase (h) IRAK-4 | sc-416405-NIC | h | Gene Knockout | Puromycin | 1 | ||
Plasmide Double Nickase (h2) IRAK-4 | sc-416405-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
Plasmide CRISPR/Cas9 KO IRAK-4 (m) | sc-435222 | m | Gene Knockout | GFP | 0 | ||
Plasmid HDR IRAK-4 (m) | sc-435222-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Plasmide Double Nickase (m) IRAK-4 | sc-435222-NIC | m | Gene Knockout | Puromycin | 0 | ||
Plasmide Double Nickase (m2) IRAK-4 | sc-435222-NIC-2 | m | Gene Knockout | Puromycin | 0 |
IRAK CRISPR Activation Products
| Empty Table Header | Nom du produit | CATALOG # | Species | Applications | MARQUEUR | CITATIONS | Classement |
|---|---|---|---|---|---|---|---|
Plasmide CRISPR d'Activation (h) IRAK-M | sc-403219-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h2) IRAK-M | sc-403219-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (h) IRAK-M | sc-403219-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (h2) IRAK-M | sc-403219-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m) IRAK-M | sc-428667-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m2) IRAK-M | sc-428667-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m) IRAK-M | sc-428667-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m2) IRAK-M | sc-428667-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h) IRAK-1 | sc-400264-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Plasmide CRISPR d'Activation (h2) IRAK-1 | sc-400264-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Particules Lentivirales d'Activation (h) IRAK-1 | sc-400264-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Particules Lentivirales d'Activation (h2) IRAK-1 | sc-400264-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Plasmide CRISPR d'Activation (m) IRAK-1 | sc-421100-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m2) IRAK-1 | sc-421100-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m) IRAK-1 | sc-421100-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m2) IRAK-1 | sc-421100-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h) IRAK-2 | sc-404304-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h2) IRAK-2 | sc-404304-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (h) IRAK-2 | sc-404304-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (h2) IRAK-2 | sc-404304-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m) IRAK-2 | sc-430883-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m2) IRAK-2 | sc-430883-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m) IRAK-2 | sc-430883-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m2) IRAK-2 | sc-430883-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (h) IRAK-4 | sc-416405-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Plasmide CRISPR d'Activation (h2) IRAK-4 | sc-416405-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Particules Lentivirales d'Activation (h) IRAK-4 | sc-416405-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Particules Lentivirales d'Activation (h2) IRAK-4 | sc-416405-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Plasmide CRISPR d'Activation (m) IRAK-4 | sc-435222-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Plasmide CRISPR d'Activation (m2) IRAK-4 | sc-435222-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m) IRAK-4 | sc-435222-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Particules Lentivirales d'Activation (m2) IRAK-4 | sc-435222-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |